Colchicine versus prednisone as treatment of usual interstitial pneumonia

Mayo Clinic Proceedings

Volumn 72, Issue 3, 1997, Pages 201-209

  Douglas, William W ^a,b,c,d,e   Ryu, Jay H ^a,b,c,d,e   Bjoraker, Julie A ^a,b,c,d,e   Schroeder, Darrell R ^a,b,c,d,e   Myers, Jeffrey L ^a,b,c,d,e   Tazelaar, Henry D ^a,b,c,d,e   Swensen, Stephen J ^a,b,c,d,e   Scanlon, Paul D ^a,b,c,d,e   Peters, Steve G ^a,b,c,d,e   Deremee, Richard A ^a,b,c,d,e  

^a Division of Pulmonary and Critical Care Medicine and Internal Medicine   (United States)

^b Division of General Internal Medicine   (United States)

^c Section of Biostatistics   (United States)

^d Division of Anatomic Pathology   (United States)

^e MAYO CLINIC ROCHESTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COLCHICINE; PREDNISONE;

ADULT; AFFECTIVE NEUROSIS; AGED; ARTICLE; CATARACT; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DIARRHEA; FEMALE; GASTRITIS; HUMAN; HYPERGLYCEMIA; INTERSTITIAL PNEUMONIA; LUNG FUNCTION TEST; MALE; MOON FACE; MYOPATHY; OPEN LUNG BIOPSY; OSTEOPOROSIS; RETROSPECTIVE STUDY; TREATMENT FAILURE; WEIGHT GAIN;

EID: 0031447814     PISSN: 00256196     EISSN: None     Source Type: Journal    
DOI: 10.4065/72.3.201     Document Type: Article

References (51)

1. Carrington CB, Gaensler EA, Coutu RE, FitzGerald MX, Gupta RG. Natural history and treated course of usual and desquamative interstitial pneumonia. N Engl J Med 1978; 298:801-809
2. Turner-Warwick M, Burrows B, Johnson A. Cryptogenic fibrosing alveolitis: clinical features and their influence on survival. Thorax 1980; 35:171-180
3. Panos RJ, King TE Jr. Idiopathic pulmonary fibrosis. In: Lynch JP III, DeRemee RA, editors. Immunologically Mediated Pulmonary Diseases. Philadelphia: Lippincott, 1991: 1-39
4. Kühn C III, Boldt J, King TE Jr, Crouch E, Vartio T, McDonald JA. An immunohistochemical study of architectural remodeling and connective tissue synthesis in pulmonary fibrosis. Am Rev Respir Dis 1989; 140:1693-1703
5. Katzenstein A-LA, Askin FB. Idiopathic interstitial pneumonia/idiopathic pulmonary fibrosis. Major Probl Pathol 1990; 13:58-96
6. Flint A, Colby TV. Surgical Pathology of Diffuse Infiltrative Lung Disease. Orlando (FL): Grune & Stratton, 1987: 106-121
7. Müller NL, Staples CA, Miller RR, Vedal S, Thurlbeck WM, Ostrow DN. Disease activity in idiopathic pulmonary fibrosis: CT and pathologic correlation. Radiology 1987; 165:731-734
8. Müller NL, Miller RR, Webb WR, Evans KG, Ostrow DN. Fibrosing alveolitis: CT-pathologic correlation. Radiology 1986; 160:585-588
9. Tung KT, Wells AU, Rubens MB, Kirk JM, du Bois RM, Hansell DM. Accuracy of the typical computed tomographic appearances of fibrosing alveolitis. Thorax 1993; 48:334-338
10. Wells AU, Rubens MB, du Bois RM, Hansell DM. Serial CT in fibrosing alveolitis: prognostic significance of the initial pattern. AJR Am J Roentgenol 1993; 161:1159-1165
11. Katzenstein AL, Fiorelli RF. Nonspecific interstitial pneumonia/fibrosis: histologie features and clinical significance. Am J Surg Pathol 1994; 18:136-147
12. Turner-Warwick M, Burrows B, Johnson A. Cryptogenic fibrosing alveolitis: response to corticosteroid treatment and its effect on survival. Thorax 1980; 35:593-599
13. Johnson MA, Kwan S, Snell NJ, Nunn AJ, Darbyshire JH, Turner-Warwick M. Randomised controlled trial comparing prednisolone alone with cyclophosphamide and low dose prednisolone in combination in cryptogenic fibrosing alveolitis. Thorax 1989; 44:280-288
14. Baughman RP, Lower EE. Use of intermittent, intravenous cyclophosphamide for idiopathic pulmonary fibrosis. Chest 1992; 102:1090-1094
15. Raghu G, Depaso WJ, Cain K, Hammar SP, Wetzel CE, Dreis DF, et al. Azathioprine combined with prednisone in the treatment of idiopathic pulmonary fibrosis: a prospective double-blind, randomized, placebo-controlled clinical trial. Am Rev Respir Dis 1991; 144:291-296
16. Izumi T, Nagai S, Kondo Y, Tamura M. Ten-year follow up of 222 patients with idiopathic pulmonary fibrosis (IPF) - a nation-wide survey report in Japan [abstract]. Am Rev Respir Dis 1992; 145(Suppl):A218
17. Wells AU, Hansell DM, Rubens MB, Cullinan P, Black CM, du Bois RM. The predictive value of appearances on thinsection computed tomography in fibrosing alveolitis. Am Rev Respir Dis 1993; 148:1076-1082
18. Hampton J, Martinez F, Orens J, Toews G, Lynch JP III. Corticosteroids in idiopathic pulmonary fibrosis (IPF): toxicity may outweigh benefits [abstract]. Am J Respir Crit Care Med 1994; 149(Suppl):A878
19. DeRemee RA. Clinical Profiles of Diffuse Interstitial Pulmonary Disease. Mount Kisco (NY): Futura, 1990: 152
20. Peters SG, McDougall JC, Douglas WW, Coles DT, DeRemee R A. Colchicine in the treatment of pulmonary fibrosis. Chest 1993; 103:101-104
21. Bjoraker JA, Edwin MK, Myers JL, Tazelaar HD, Offord KP, Schroeder DR, et al. Prognosis in idiopathic pulmonary fibrosis [abstract]. Chest 1995; 108(Suppl):158S
22. Rodarte JR, Hyatt RE, Westbrook PR. Determination of lung volume by single- and multiple-breath nitrogen washout. Am Rev Respir Dis 1976; 114:131-136
23. Beck KC, Hyatt RE, Staats B A, Enright PL, Rodarte JR. Carbon monoxide diffusing capacity of the lungs determined by single-breath and steady-state exercise methods. Mayo ClinProc 1989; 64:51-59
24. Cotes JE, Dabbs JM, Elwood PC, Hall AM, McDonald A, Saunders MJ. Iron-deficiency anaemia: its effect on transfer factor for the lung (diffusing capacity) and ventilation and cardiac frequency during sub-maximal exercise. Clin Sci 1972; 42:325-335
25. Miller A, Thornton JC, Warshaw R, Anderson H, Teirstein AS, Selikoff IJ. Single breath diffusing capacity in a representative sample of the population of Michigan, a large industrial state: predicted values, lower limits of normal, and frequencies of abnormality by smoking history. Am Rev Respir Dis 1983; 127:270-277
26. Miller A, Thornton JC, Warshaw R, Bernstein J, Selikoff IJ, Teirstein AS. Mean and instantaneous expiratory flows, FVC and FEV1 : prediction equations from a probability sample of Michigan, a large industrial state. Bull Eur Physiopathol Respir 1986; 22:589-597
27. Bates DV, Macklem PT, Christie RV. Respiratory Function in Disease. 2nd ed. Philadelphia: Saunders, 1971: 261
28. American Thoracic Society. Lung function testing: selection of reference values and interpretative strategies. Am Rev Respir Dis 1991; 144:1202-1218
29. American Thoracic Society. Single breath carbon monoxide diffusing capacity (transfer factor): recommendations for a standard technique. Am Rev Respir Dis 1987; 136:1299-1307
30. Flower RJ, Moncada S, Vane JR. Drug therapy of inflammation. In: Oilman AG, Goodman LS, Rail TW, Murad F, editors. Goodman and Oilman's The Pharmacological Basis of Therapeutics. 7th ed. New York: Macmillan, 1985: 708-710
31. Zemer D, Livneh A, Danon YL, Präs M, Sohar E. Long-term colchicine treatment in children with familial Mediterranean fever. Arthritis Rheum 1991; 34:973-977
32. Schwarz YA, Kivity S, Ilfeld DN, Schlesinger M, Greif J, Topilsky M, et al. A clinical and immunologie study of colchicine in asthma. J Allergy Clin Immunol 1990; 85:578-582
33. Alarçon-Segovia D, Ramos-Niembro F, Ibanez de Kasep G, Alcocer J, Tamayo RP. Long-term evaluation of colchicine in the treatment of scleroderma. J Rheumatol 1979; 6:705-712
34. Guindo F, Rodriguez de la Serna A, Ramio J, de Miguel Diaz MA, Subirana MT, Perez Ayuso MJ, et al. Recurrent pericarditis: relief with colchicine. Circulation 1990; 82:1117-1120
35. Strother SV, Zuckerman KS, LoBuglio AF. Colchicine therapy for refractory idiopathic thrombocytopenic purpura. Arch Intern Med 1984; 144:2198-2200
36. Plotnick S, Huppert AS, Kantor G. Colchicine and leukocytoclastic vasculitis [letter]. Arthritis Rheum 1989; 32:1489-1490
37. Kaplan MM, Alling DW, Zimmerman HJ, Wolfe HJ, Sepersky RA, Hirsch GS, et al. A prospective trial of colchicine for primary biliary cirrhosis. N Engl J Med 1986; 315:1448-1454
38. Younger DS, Mayer SA, Weimer LH, Alderson LM, Seplowitz AH, Lovelace RE. Colchicine-induced myopathy and neuropathy. Neurology 1991; 41:943
39. Wallace SL, Singer JZ, Duncan GJ, Wigley FM, Kuncl RW. Renal function predicts colchicine toxicity: guidelines for the prophylactic use of colchicine in gout. J Rheumatol 1991; 18:264-269
40. Finklestein M, Goldman L, Grace ND, Foley M, Randall N. Granulocytopenia complicating colchicine therapy for primary biliary cirrhosis. Gastroenterology 1987; 93:1231-1235
41. Frank RS. Time-dependent alterations in the deformability of human neutrophils in response to chemotactic activation. Blood 1990; 76:2606-2612
42. Grunspan-Swirsky A, Pick E. Enhancement of macrophage adenylate cyclase by microtubule disrupting drugs. Immunopharmacology 1978; 1:71-82
43. Rennard SI, Bitterman PB, Ozaki T, Rom WN, Crystal RG. Colchicine suppresses the release of fibroblast growth factors from alveolar macrophages in vitro: the basis of a possible therapeutic approach to the fibrotic disorders. Am Rev RespirDis 1988; 137:181-185
44. Ehrlich HP, Bornstein P. Microtubules in transcellular movement of procollagen. Nature 1972; 238:257-260
45. Damji KF, Rootman J, Palcic B, Thurston G. Pharmacological modulation of human subconjunctival fibroblast behavior in vitro. Ophthalmic Surg 1990; 21:31-43
46. Mathieson JR, Mayo JR, Staples CA, Müller NL. Chronic diffuse infiltrât!ve lung disease: comparison of diagnostic accuracy of CT and chest radiography. Radiology 1989; 171:111-116
47. Park JS, Lee KS, Kim JS, Park CS, Suh YL, Choi DL, et al. Nonspecific interstitial pneumonia with fibrosis: radiographic and CT findings in seven patients. Radiology 1995; 195:645-648
48. Silver SF, Müller NL, Miller RR, Lefcoe MS. Hypersensitivity pneumonitis: evaluation with CT. Radiology 1989; 173:441-445
49. Adler BD, Padley SP, Müller NL, Remy-Jardin M, Remy J. Chronic hypersensitivity pneumonitis: high-resolution CT and radiographie features in 16 patients. Radiology 1992; 185:91-95
50. Buschman DL, Gamsu G, Waldron JA Jr, Klein JS, King TE Jr. Chronic hypersensitivity pneumonitis: use of CT in diagnosis. AJR Am J Roentgenol 1992; 159:957-960
51. Lynch DA, Newell JD, Logan PM, King TE Jr, Müller NL. Can CT distinguish hypersensitivity pneumonitis from idiopathic pulmonary fibrosis? AJR Am J Roentgenol 1995; 165:807-811